Pang H - Search Results

1

Estimating treatment effect in randomized trial after control to treatment crossover using external controls.

Zhou X, Pang H, Drake C, Burger HU, Zhu J. Zhou X, et al. Among authors: pang h. J Biopharm Stat. 2024 Apr 1:1-29. doi: 10.1080/10543406.2024.2330209. Online ahead of print. J Biopharm Stat. 2024. PMID: 38557220

2

Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.

Fu C, Pang H, Zhou S, Zhu J. Fu C, et al. Among authors: pang h. Pharm Stat. 2023 Jul-Aug;22(4):619-632. doi: 10.1002/pst.2297. Epub 2023 Mar 7. Pharm Stat. 2023. PMID: 36882191

3

Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.

Wang X, Bai F, Pang H, George SL. Wang X, et al. Among authors: pang h. J Biopharm Stat. 2019;29(4):592-605. doi: 10.1080/10543406.2019.1633659. Epub 2019 Jul 9. J Biopharm Stat. 2019. PMID: 31286838 Free PMC article.

4

Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

Yuan J, Pang H, Tong T, Xi D, Guo W, Mesenbrink P. Yuan J, et al. Among authors: pang h. J Biopharm Stat. 2016;26(5):912-23. doi: 10.1080/10543406.2015.1094807. Epub 2015 Sep 21. J Biopharm Stat. 2016. PMID: 26390951 Free PMC article.

5

Random Effects Model for Multiple Pathway Analysis with Applications to Type II Diabetes Microarray Data.

Pang H, Kim I, Zhao H. Pang H, et al. Stat Biosci. 2015 Oct 1;7(2):167-186. doi: 10.1007/s12561-014-9109-1. Epub 2014 Jan 30. Stat Biosci. 2015. PMID: 26640601 Free PMC article.

6

Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials.

Wang F, Schilsky RL, Page D, Califf RM, Cheung K, Wang X, Pang H. Wang F, et al. Among authors: pang h. JAMA Netw Open. 2020 Oct 1;3(10):e2014661. doi: 10.1001/jamanetworkopen.2020.14661. JAMA Netw Open. 2020. PMID: 33030549 Free PMC article.

7

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.

Vlahovic G, Meadows KL, Hatch AJ, Jia J, Nixon AB, Uronis HE, Morse MA, Selim MA, Crawford J, Riedel RF, Zafar SY, Howard LA, O'Neill M, Meadows JJ, Haley ST, Arrowood CC, Rushing C, Pang H, Hurwitz HI. Vlahovic G, et al. Among authors: pang h. Oncologist. 2018 Jul;23(7):782-790. doi: 10.1634/theoncologist.2016-0377. Epub 2018 Mar 23. Oncologist. 2018. PMID: 29572245 Free PMC article. Clinical Trial.

8

Assessing surrogacy using restricted mean survival time ratio for overall survival in liver cancer: a narrative review.

Leung TH, Ho JC, Wang X, Pang H. Leung TH, et al. Among authors: pang h. Chin Clin Oncol. 2023 Oct;12(5):53. doi: 10.21037/cco-23-48. Epub 2023 Sep 22. Chin Clin Oncol. 2023. PMID: 37817506 Free article. Review.

9

New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach.

Leung TH, Ho JC, El Helali A, Vokes EE, Wang X, Pang H. Leung TH, et al. Among authors: pang h. Ann Transl Med. 2023 Jan 15;11(1):2. doi: 10.21037/atm-22-2160. Epub 2023 Jan 4. Ann Transl Med. 2023. PMID: 36760246 Free PMC article.

10

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.

Liu Y, Starr MD, Bulusu A, Pang H, Wong NS, Honeycutt W, Amara A, Hurwitz HI, Nixon AB. Liu Y, et al. Among authors: pang h. Cancer Med. 2013 Apr;2(2):234-42. doi: 10.1002/cam4.71. Epub 2013 Mar 6. Cancer Med. 2013. PMID: 23634291 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,413 results

Search Page